Page last updated: 2024-10-31

midazolam and Agranulocytosis

midazolam has been researched along with Agranulocytosis in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perrichot, R1
Reman, O1
Hurault de Ligny, B1
Albengres, E1
Batho, A1
Ryckelynck, JP1
Leporrier, M1

Other Studies

1 other study available for midazolam and Agranulocytosis

ArticleYear
[Agranulocytosis induced by diazepam and then midazolam. Role of antibodies].
    Presse medicale (Paris, France : 1983), 1990, Apr-21, Volume: 19, Issue:16

    Topics: Agranulocytosis; Antibodies; Diazepam; Humans; Male; Midazolam; Middle Aged; Radioimmunoprecipitatio

1990